In vitro: reduction of β-amyloid plaques SH-SY5Y and APP-CHO cells [225].In vivo: reducing in brain iron accompanied by a significantly reducing in brain deposition of Aβ-40 and Aβ-42 and Aβ plaques; improve improves cognitive impairments [224]. This evidence concerns the gene APP and Cognitive impairment.